β-blocker-associated risks in patients with uncomplicated hypertension undergoing noncardiac surgery

JAMA Internal Medicine

Volumn 175, Issue 12, 2015, Pages 1923-1931

  Jørgensen, Mads E ^a   Hlatky, Mark A ^b   Køber, Lars ^a   Sanders, Robert D ^c   Torp Pedersen, Christian ^d   Gislason, Gunnar H ^a,e   Jensen, Per Føge ^a   Andersson, Charlotte ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d AALBORG UNIVERSITY   (Denmark)

^e Department of Cardiovascular Epidemiology and Research   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; THIAZIDE DIURETIC AGENT;

ACUTE HEART INFARCTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ADULT; CAUSE OF DEATH; CHEMICALLY INDUCED; COMPLICATION; DENMARK; FOLLOW UP; GENERAL SURGERY; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREOPERATIVE PERIOD; PROGNOSIS; PROPENSITY SCORE; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; STROKE; TRENDS; YOUNG ADULT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CAUSE OF DEATH; DENMARK; FEMALE; FOLLOW-UP STUDIES; GENERAL SURGERY; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREOPERATIVE PERIOD; PROGNOSIS; PROPENSITY SCORE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 84947814807     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.5346     Document Type: Article

References (48)

1. Cole GD, Francis DP. The challenge of delivering reliable science and guidelines: opportunities for all to participate. Eur Heart J. 2014;35(36):2435-2440.
2. Erasmus MC Follow-up Investigation Committee. Report on the 2012 follow-up investigation of possible breaches of academic integrity. 2012. https://cardiobrief.files.wordpress.com/2012/10/integrity-report-2012-10-english-translation.pdf. Accessed February 26, 2015.
3. Bouri S, Shun-Shin MJ, Cole GD, Mayet J, Francis DP. Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery. Heart. 2014;100(6):456-464.
4. Blessberger H, Kammler J, Domanovits H, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity. Cochrane Database Syst Rev. 2014;9:CD004476.
5. Wijeysundera DN, Duncan D, Nkonde-Price C, et al; ACC/AHA Task Force Members. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(24): 2246-2264.
6. Andersson C, Mérie C, Jørgensen M, et al. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. JAMA Intern Med. 2014;174(3):336-344.
7. Warltier DC, Pagel PS, Kersten JR. Approaches to the prevention of perioperative myocardial ischemia. Anesthesiology. 2000;92(1):253-259.
8. Fleisher LA, Fleischmann KE, Auerbach AD, et al; American College of Cardiology; American Heart Association. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64 (22):e77-e137.
9. Kristensen SD, Knuuti J, Saraste A, et al; Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J. 2014;35 (35):2383-2431.
10. Lüscher TF, Gersh B, Landmesser U, Ruschitzka F. Is the panic about beta-blockers in perioperative care justified? Eur Heart J. 2014;35(36):2442-2444.
11. Wijeysundera DN, Duncan D, Nkonde-Price C, et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64(22):2406-2425.
12. Devereaux PJ, Yang H, Yusuf S, et al; POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839-1847.
13. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients: the modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation. 1976;53(4):720-727.
14. Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308(9):875-881.
15. Stone JG, Foëx P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology. 1988;68(4):495-500.
16. Stone JG, Foëx P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. Br J Anaesth. 1988;61(6):675-679.
17. Abildstrøm SZ, Torp-Pedersen C, Madsen M. Register-based studies of cardiovascular disease. Scand J Public Health. 2011;39(7)(suppl):165-169.
18. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7)(suppl):30-33.
19. Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011;39(7) (suppl):26-29.
20. Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7)(suppl):38-41.
21. Gaist D, Sørensen HT, Hallas J. The Danish prescription registries. Dan Med Bull. 1997;44(4): 445-448.
22. Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342: d124.
23. Andersson C, Norgaard ML, Hansen PR, et al. Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study. Eur J Heart Fail. 2010;12(12):1333-1338.
24. Andersson C, Lyngbæk S, Nguyen CD, et al. Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes. JAMA. 2012;308(9):882-889.
25. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.
26. Nordic-Medico-Statistical-Committee. NOMESCO Classification of Surgical Procedures. 2010. http://nowbase.org/Publikationer/~/media/Projekt%20sites/Nowbase/Publikationer/NCSP/NCSP%201-14.ashx. Accessed September 1, 2015.
27. Jørgensen ME, Torp-Pedersen C, Gislason GH, et al. Time elapsed after ischemic stroke and risk of adverse cardiovascular events and mortality following elective noncardiac surgery. JAMA. 2014; 312(3):269-277.
28. Bender R, Vervölgyi V. Estimating adjusted NNTs in randomised controlled trials with binary outcomes: a simulation study. Contemp Clin Trials. 2010;31(5):498-505.
29. Bender R, Vervölgyi V. Calculation of the number needed to treat (NNT) and 95% confidence intervals with adjustment for balanced covariates in RCTS. 2010. http://www.rbsd.de/SOFTWARE/nnt-adj.sas. Accessed July 9, 2015.
30. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet. 2008;372(9654):1962-1976.
31. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2009. J Am Coll Cardiol. 2009;54(22):e13-e118.
32. Auerbach AD, Goldman L. β-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA. 2002;287(11):1435-1444.
33. Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Gentile G, Reboldi G. β-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery. Am J Cardiovasc Drugs. 2010;10(4):247-259.
34. Devereaux PJ, Beattie WS, Choi PT-L, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;331(7512):313-321.
35. Stevens RD, Burri H, Tramèr MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg. 2003;97(3):623-633.
36. McGory ML, Maggard MA, Ko CY. A meta-analysis of perioperative beta blockade: what is the actual risk reduction? Surgery. 2005;138(2): 171-179.
37. Wiesbauer F, Schlager O, Domanovits H, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg. 2007;104(1):27-41.
38. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4): 349-361.
39. London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA. 2013;309(16): 1704-1713.
40. Kertai MD, Westerhout CM, Varga KS, Acsady G, Gal J. Dihydropiridine calcium-channel blockers and perioperative mortality in aortic aneurysm surgery. Br J Anaesth. 2008;101(4):458-465.
41. Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg. 2003;97(3):634-641.
42. Shah M, Jain AK, Brunelli SM, et al. Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis. BMC Nephrol. 2014;15:53.
43. Lau WC, Froehlich JB, Jewell ES, et al. Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery. Ann Vasc Surg. 2013;27(4):537-545.
44. Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2012;11: CD002003.
45. Dahlöf B, Sever PS, Poulter NR, et al; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895-906.
46. Dahlöf B, Devereux RB, Kjeldsen SE, et al; LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002; 359(9311):995-1003.
47. Bang LE, Bruun NE, Christensen KL, Ibsen H, Svendsen TL. Guidelines for the treatment of arterial hypertension [in Danish]. 2009. Danish Hypertension Society website. http://dahs.dk/fileadmin/Behandlingsvejled0910-endelig-printversion.pdf.
48. Richards TR, Tobe SW. Combining other antihypertensive drugs with β-blockers in hypertension: a focus on safety and tolerability. Can J Cardiol. 2014;30(5)(suppl):S42-S46.